MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED)

NCT00482729 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1246

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: sitagliptin phosphate (+) metformin hydrochloride
DRUG: metformin

Sponsor

Merck Sharp & Dohme LLC